Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E McNeil

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Challenges for nanoparticle characterizationScott E McNeil
Journal of Leukocyte Biology|June 1, 2005
Nanotechnology for the biologistScott E McNeil
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 6, 2010
Nanoparticle therapeutics: a personal perspectiveScott E McNeil
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Unique benefits of nanotechnology to drug delivery and diagnosticsScott E McNeil
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 3, 2007
Nanotechnology safety concerns revisitedStephan T Stern, Scott E McNeil
Expert Opinion on Drug Delivery|May 22, 2015
Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeuticsMarina A Dobrovolskaia, Scott E McNeil
Expert Opinion on Biological Therapy|May 29, 2015
Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeuticsMarina A Dobrovolskaia, Scott E McNeil
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 8, 2013
Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicinesMarina A Dobrovolskaia, Scott E McNeil
Annals of Translational Medicine|June 6, 2015
Safe anticoagulation when heart and lungs are "on vacation"Marina A Dobrovolskaia, Scott E McNeil
Nature Nanotechnology|July 26, 2008
Immunological properties of engineered nanomaterialsMarina A Dobrovolskaia, Scott E McNeil
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Challenges for nanoparticle characterizationScott E McNeil
Journal of Leukocyte Biology|June 1, 2005
Nanotechnology for the biologistScott E McNeil
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 6, 2010
Nanoparticle therapeutics: a personal perspectiveScott E McNeil
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Unique benefits of nanotechnology to drug delivery and diagnosticsScott E McNeil
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 3, 2007
Nanotechnology safety concerns revisitedStephan T Stern, Scott E McNeil
Expert Opinion on Drug Delivery|May 22, 2015
Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeuticsMarina A Dobrovolskaia, Scott E McNeil
Expert Opinion on Biological Therapy|May 29, 2015
Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeuticsMarina A Dobrovolskaia, Scott E McNeil
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 8, 2013
Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicinesMarina A Dobrovolskaia, Scott E McNeil
Annals of Translational Medicine|June 6, 2015
Safe anticoagulation when heart and lungs are "on vacation"Marina A Dobrovolskaia, Scott E McNeil
Nature Nanotechnology|July 26, 2008
Immunological properties of engineered nanomaterialsMarina A Dobrovolskaia, Scott E McNeil
Pageof 6